Rhesus-associated glycoprotein (RhAG) phenotype of the red blood cells modulates T. gondii infection-associated psychomotor performance reaction times and changes in the human personality profile. Impaired function of the CO2, AQP1, and AQP4 gas channels may cause hypoxia and thus enhance neuroinflammation in autistic individuals

Neuroinflammation: Pathogenesis, Mechanisms and Management

Volumn , Issue , 2012, Pages 423-440

  Prandota, Joseph ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Aquaporin 1; Autism spectrum disorders; Brain aquaporin 4; Changes of personality profile; Hypoxia; Latent cerebral toxoplasmosis; Neuroinflammation; Red blood cell membrane CO2 permeability; RhAG phenotype; T. gondii infection

Indexed keywords

EID: 84876059874     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (122)

1. Dubey, J.P., & Beattie, C.P. Toxoplasmosis of animals and man. Boca Raton, FL: CRC Press, 1988, p. 220.
2. Tenter, A.M., Heckeroth, A.R., & Weiss, L.M. Toxoplasma gondii: from animals to humans. International Journal of Parasitology 2000, 30: 1217-1258.
3. Boyer, K., Marcinak, J., & McLeod, R. Toxoplasma gondii (Toxoplasmosis). In Principles and Practice of Pediatric Infectious Diseases 3rd ed. 2007, Edited by: Long, S., Pickering, L.K., Prober, C.G. New York: Churchill Livingstone.
4. Carruthers, V.B. & Suzuki, Y. Effects of Toxoplasma gondii infection on the brain. Schizophrenia Bulletin 2000, 33: 745-751.
5. McLeod, R., & Remington, J.S. Toxoplasmosis. In R.E. Behrman, R.M. Kliegman, W.E. Nelson, & V.C. Vaughan (Eds.), Nelson textbook of pediatrics 1992, (14th ed., pp. 883-892). Philadelphia: WB Saunders Co.
6. Flegr, J. Effects of Toxoplasma on human behavior. Schizophrenia Bulletin 2007, 33: 757-760.
7. Costa da Silva, R., & Langoni, H. Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitology Research 2009, 105: 893-898.
8. Vastava, P.B., Pradhan, S., Jha, S., Prasad, K.N., Kumar, S., & Gupta, R.K. MRI features of toxoplasma encephalitis in the immunocompetent host: A report of two cases. Neuroradiology 2002, 44: 834-838.
9. Lescop, J., Brinquin, L., Schill, H., Soulie, D., Sarrazin, J.L., & Cordoliani, Y.S. Diffuse toxoplasmic encephalitis in a non-immunosuppressed patient. Journal of Radiology 1995, 76: 21-24.
10. Vallochi, A.l., Goldberg, A.C., Falcai, A., Ramasawmy, R., Kalil, J., et al. Molecular markers of susceptibility to ocular toxoplasmosis, host and guest badly. Clinical Ophthalmology 2008, 2: 837-848.
11. Prandota, J. The importance of Toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction. International Journal of Neuroscience 2009, 119: 2144-2182.
12. Flegr, J., & Havlicek, J. Changes in the personality profile of young women with latent toxoplasmosis. Folia Parasitologica 1999, 46: 22-28.
13. Flegr, J., Kodym, P., & Talarova, V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biological Psychology 2000, 53: 57-68.
14. Lafferty, K.D. Can the common brain parasite, Toxoplasma gondii, influence human culture?. Proceedings, Biological Sciences The Royal Society 2006, 273: 2749-2755.
15. Flegr, J., Novotna, M., Lindova, J., & Havlicek, J. Neurophysiological effect of the Rh factor. Protective role of the RhD molecule against Toxoplasma-induced impairment of reaction time in women. Neuro Endocrinology Letters 2008, 29: 475-481.
16. Flegr, J., Klose, J., Novotna, M., Berenreitterova, M., & Havlicek, J. Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infectious Diseases 2009, 9: e72.
17. Flegr, J., Novotna, M., Fialova, A., Kolbekova, P., & Gasova, Z. The influence of RhD phenotype on toxoplasmosis-and age-associated changes in personality profile of blood donors. Folia Parasitologica 2010, 57: 143-150.
18. Novotna, M., Havlicek, J., Smith, A.P., Kolbekova, P., Skallova, A., Klose, J., et al. Toxoplasma and reaction time: role of toxoplasmosis in the origin, preservation and geographical distribution of Rh blood group polymorphism. Parasitology 2008, 135: 1253-1261.
19. Kankova, S., Sulc, J., & Flegr, J. Increased pregnancy weight gain in women with latent toxoplasmosis and RhD-positivity protection against this effect. Parasitology 2010, Jul 6:1-7 [Epub ahead o print].
20. Ridgwell, K., Tanner, M.J., & Anstee, D.J. The Rhesus (D) polypeptide is linked to the human erythrocyte cytoskeleton. FEBS Letters 1984, 174: 7-10.
21. Ridgwell, K., Spurr, N.K., Laguda, B., MacGeoch, C., Avent, N.D., & Tanner, M.J. Isolation of cDNA clones for a 50 kDa glycoprotein of the human erythrocyte membrane associated with Rh (rhesus) blood-group antigen expression. Biochemical Journal 1992, 287: 223-228.
22. Van Kim, C.L., Colin, Y., & Cartron, J.P. Rh proteins: key structural and functional components of the red cell membrane. Blood Reviews 2006, 20: 93-110.
23. Kustu, S., & Inwood, W. Biological gas channels for NH3 and CO2: evidence that Rh (Rhesus) proteins are CO2 channels. Transfusion Clinique et Biologique 2006, 13: 103-110.
24. Callebaut, I., Dulin, F., Bertrand, O., Ripoche, P., Mouro, I., Colin, Y., et al. Hydrophobic cluster analysis and modeling of the human Rh protein three-dimensional structures. Transfusion Clinique et Biologique 2006, 13: 70-84.
25. Beckmann, R., Smythe, J.S., Anstee, D.J., & Tanner, M.J. Coexpression of band 3 mutants and Rh polypeptides: differential effects of band 3 on the expression of the Rh complex containing D polypeptide and the Rh complex containing CcEe polypeptide. Blood 2001, 97: 2496-2505.
26. Huang, C.H., & Liu, P.Z. New insights into the Rh superfamily of genes and proteins in erythroid cells and nonerythroid tissues. Blood Cells and Molecular Diseases 2001, 27: 90-101.
27. Walensky, L.D., Narla, M., Lux, S.E. Disorders of the red cell membrane. In: Handin RI, Lux IV SE, Stossel TP (eds). Blood: Principles and Practice of Hematology, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins 2003, pp. 1709-1858.
28. Endeward, V., Musa-Aziz, R., Cooper, G.J., Chen, L., Pelletier, M.F., Virkki, V., et al. Evidence that aquaporin 1 is the major pathway for CO2 transport across the human erythrocyte membrane. FASEB Journal 2006, 20: 1974-1981.
29. Endeward, V., Cartron, J.-P., Ripoche, P., & Gros, G. RhAG protein of the Rhesus complex is a CO2 channel in the human red cell membrane. FASEB Journal 2008, 22: 64-73.
30. Blank, M.E., & Ehmke, H. Aquaporin-1 and HCO3--Cl transporter-mediated transport of CO2 across the human erythrocyte membrane. Journal of Physiology 2003, 550: 419-429.
31. Uehlein, N., Lovisolo, C., Seifritz, F., & Kaldenhoff, R. The tobacco aquaporin NtAQP1 is a membrane CO2 pore with physiological functions. Nature 2003, 425: 734-737.
32. Wang, Y., Cohen, J., Boron, W.F., Schulten, K., & Tajkhorshid, E. Exploring gas permeability of cellular membranes and membrane channels with molecular dynamics. Journal of Structural Biology 2007, 157: 534-544.
33. Echevarria, M., Munoz-Cabello, A.M., Sanchez-Silva, R., Toledo-Aral, J.J., & Lopez-Barneo, J. Development of cytosolic hypoxia and hypoxia-inducible factor stabilization are facilitated by aquaporin-1 expression. Journal of Biological Chemistry 2007, 282: 30207-30215.
34. Herrera, M., Hong, N.J., & Garvin, J.L. Aquaporin-1 transports NO across cell membranes. Hypertension 2006, 48: 157-164.
35. Musa-Aziz, R., Chen, L.-M., Pelletier, M.F., & Boron, W.F. Relative CO2/NH3 selectivities of AQP1, AQP4, AQP5, AmtB, and RhAg. Proceedings of the National Academy of Sciences USA 2009, 106: 5406-5411.
36. Bruce, L.J., Beckmann, R., Ribeiro, M.L., Peters, L.L., Chasis, J.A., Delaunay, J., et al. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 2003, 101: 4180-4188.
37. Cho, M.R., Knowles, D.W., Smith, B.L., Moulds, J.J., Agre, P., Mohanda, N., & Golan, D.E. Membrane dynamics of the water transport protein aquaprotein-1 in intact human red cells. Biophysical Journal, 1999, 76: 1136-1144.
38. Rossignol, D.A. Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Medical Hypotheses 2007, 68: 1208-1227.
39. Nagelhus, E.A., Veruki, M.L., Torp, R., Haug, F.M., Laake, J.H., et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Muller cells and fibrous astrocytes. Journal of Neuroscience 1998, 18: 2506-2519.
40. Zelenina, M. Regulation of brain aquaporins. Neurochemistry International 2010, doi: 10.1016/j.neuint.2010.03.022.
41. Amiry-Moghaddam M, Frydenlund DS, Ottersen OP. Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience, 2004, 129: 999-1010.
42. Yang, B., Ma, T., & Verkman, A.S. cDNA cloning, gene organization, and chromosomal localization of a human mercurial insensitive water channel. Evidence for distinct transcriptional units. Journal of Biological Chemistry 1995, 270: 22907-22913.
43. Nagelhus, E.A., Mathiisen, T.M., & Ottersen, O.P. Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 2004, 129: 905-913.
44. Badaut, J., Lasbennes, F., Magistretti, P.J., & Regli, L. Aquaporin in brain: distribution, physiology, and pathophysiology. Cerebral Blood Flow and Metabolism 2002, 22: 367-378.
45. Rash, J.E., Yasumura, T., Hudson, C.S., Agre, P., & Nielsen, S. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proceedings of the National Academy of Sciences USA 1998, 95: 11981-11986.
46. Verkman, A.S., Binder, D.K., Bloch, O., Auguste, K., & Papadopoulos, M.C. Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochimica et Biophysica Acta 2006, 1758: 1085-1093.
47. Speake, T., Freeman, L.J., & Brown, P.D. Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus. Biochimica and Biophysica Acta 2003, 1609: 80-86.
48. Bloch, O., Auguste, K.I., Manley, G.T., & Verkman, A.S. Accelerated progression of kaolin-induced hydrocephalus in aquaporin 4-deficient mice. Journal of Cerebral Blood Flow and Metabolism 2007, 26: 1527-1537.
49. Fatemi, H.S., Folsom, T.D., Reutiman, T.J., & Lee, S. Expression of astrocyte markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse 2008, 62: 501-507.
50. Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008, 131: 3072-3080.
51. Graber, D.J., Levy, M., Kerr, D., & Wade, W.F. Neuromyelitis optica pathogenesis and aquaporin 4. Journal of Neuroinflammation 2008, 5: 22.
52. Nicchia, G.P., Srinivas, M., Lei, W., Brosnan, C.F., Frigeri, A., & Spray, D.C. New possible roles for aquaporin-4 in astrocytes: cell skeleton and functional relationship with connexin 43. FASEB Journal 2005, 19: 1674-1676.
53. Amiry-Moghaddam, M., Williamson, A., Palomba, M., Eid, T., de Lanerolle, N.C., Nagelhus, E.A., et al. Delayed K+ clearance associated with aquaporin-4 mislocalization: phenotype defects in brains of alpha-syntrophin-null mice. Proceedings of the National Academy of Sciences USA 2003, 100: 13615-13620.
54. Binder, D.K., Oshio, K., Ma, T., Verkman, A.S., & Manley, G.T. Increased seizure threshold in mice lacking aquaporin-4 water channel. Neuroreport 2004, 15: 419-429.
55. Binder, D.K., Yao, X., Verkman, A.S., & Manley, G.T. Increased seizures duration in mice lacking aquaporin-4 water channels. Acta Neurochirurgica Suppl 2006, 96: 389-392.
56. Vitellaro-Zuccarello, L., Mazzetti, S., Bosisio, P., Monti, C., & De Biasi, S. Distribution of aquaporin 4 in rodent spinal cord: relationship with astrocyte markers and chondroitin sulfate proteoglycans. Glia 2005, 51: 148-159.
57. Mathiisen, T.M., Lehre, K.P., & Danbolt, N.C. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 2010, 58: 1094-1103.
58. Lüder, C.G.K., Giraldo-Velasquez, M., Sendtner, M., & Gross, U. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Experimental Parasitology 1999, 93: 23-32.
59. Singh, V.K., Warren, R., Averett, R., & Ghaziuddin, M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology 1997, 17: 88-90.
60. Singer, H.S., Morris, C.M., Williams, P.N., Yoon, D.Y., Hong, J.J., & Zimmerman, A.W. Antibrain antibodies in children with autism and their unaffected siblings. Journal of Neuroimmunology 2006, 178: 149-155.
61. Connolly, A.M., Chez, M.G., Pestronk, A., Arnold, S.T., Mehta, S., & Deuel, R.K. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics 1999, 134: 607-613.
62. Vojdani, A., Campbell, A.W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. Journal of Neuroimmunology 2002, 129: 168-177.
63. Fagard R, Van Tan H, Creuzet C, & Pelloux H Differential development of Toxoplasma gondii in neural cells. Parasitology Today 1999, 15: 504-507.
64. Halonen, S.K., Weiss, L.M., & Chiu, F.C. Association of host cell intermediate filaments with Toxoplasma gondii cysts in murine astrocytes n vitro. International Journal of Parasitology 1998, 28: 815-823.
65. Wilson, E.H., & Hunter, C.A. The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis. International Journal of Parasitology 2004, 34: 543-548.
66. Fatemi, S.H., Laurence, J., Araghi-Niknam, M., Stary, J.M., & Rizvi, S. Glial fibrillary acidic protein is elevated in superior frontal and parietal cortices of autistic subjects. International Journal of Neuropsychopharmacology 2002, 5: 153-154.
67. Laurence, J.A., & Fatemi, S.H. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 2005, 4: 206-210.
68. Gunnarson, E., Zelenina, M., & Aperia, A. Regulation of brain aquaporins. Neuroscience 2004, 129: 947-955.
69. Fujita, Y., Yamamoto, N., Sobue, K., Inagaki, M., Ito, H., Arima, H., et al. Effect of mild hypothermia on the expression of aquaporin family in cultured rat astrocytes under hypoxic condition. Neuroscience Research 2003, 47: 437-444.
70. Aoki, K., Uchihara, T., Tsuchiya, K., Nakamura, A., Ikeda, K., & Wakayama, Y. Enhanced expression of aquaporin 4 in human brain with infarction. Acta Neuropathologica (Berl) 2003, 106: 121-124.
71. Taniguchi, M., Yamashita, T., Kumura, E., Tamatani, M., Kobayashi, A., Yokawa, T., et al. Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Research, Molecular Brain Research 2000, 78: 131-137.
72. Fatemi, S.H., Pearce, D.A., Brooks, A.I., & Sidwell, R.W. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 2005, 57: 91-99.
73. Fatemi, S.H., Folsom, T.D., Reutiman, T.J., & Sidwell, R.W. Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin. Schizophrenia Research 2008, 98, 163-177.
74. DiCicco-Bloom, E., Lord, C., Zwaigenbaum, L., Courchesne, E., Dager, S.R., et al. The developmental neurobiology of autism spectrum disorder. Journal of Neuroscience 2006, 26: 6897-6906.
75. Rajnarayanan, R., Varadharajan, S., Isokpehi, R., & Cohly, H. (2009) Potential role of cation-aquaporin interaction in autism. Biomedical & Engineering Conference, BSEC 2009, First Annual ORNL. Doi: 10.1109/BSEC.2009.5090494.
76. Waly, M., Olteanu, H., Banerjee, R., Choi, S.-W., Mason, J.B., Parker, B.S., et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: A target for neurodevelopmental toxins and thimerosal. Molecular Psychiatry 2004, 9: 358-370.
77. King, M.D., Lindsay, D.S., Holladay, S., & Ehrich, M. Neurotoxicity and immunotoxicity assessment in CBA/J mice with chronic Toxoplasma gondii infection and single-dose exposure to methylmercury. Int J Toxicol 2003, 22:53-61.
78. Ghatak, N.R., & Sawyer, D.R. A morphologic study of opportunistic cerebral toxoplasmosis. Acta Neuropathologica 1978, 42: 217-221.
79. Peterson, P.K., Gekker, G., Hu, S., & Chao, C.C. Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. Journal of Infectious Diseases 1993, 168: 1472-1478.
80. Halonen, S.K., Lyman, W.D., & Chiu, F.C. Growth and development of Toxoplasma gondii in human neurons and astrocytes. Journal of Neuropathology and Experimental Neurology 1996, 55, 154-1150-1156.
81. Falangola, M.F., & Petito, C.K. Choroid plexus infection in cerebral toxoplasmosis in AIDS patients. Neurology 1993, 43: 2035-2040.
82. Fatemi, S.H., Halt, A.R., Earle, J., Kist, D.A., Realmuto, G.R., et al. Reduced Purkinje cell size in autistic cerebellum. Biological Psychiatry 2000, 47: S128.
83. Ritvo, E.R., Freeman, B.J., Scheibel, A.B., Duong, T., Robinson, H., et al. Lower Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research report. American Journal of Psychiatry 1986, 143: 862-866.
84. Stommel, E.W., Seguin, R., Thadani, V.M., Schwartzman, J.D., Gilbert, K., Ryan, K.A., et al. Cryptogenic epilepsy: an infectious etiology. Epilepsia 2001, 42: 436-438.
85. Yazar, S., Arman, F., Yalcin, S., Demirtas, F., Yaman, O., & Sahin, I. Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seizure 2003, 12: 107-109.
86. Hrdlicka, M. EEG abnormalities, epilepsy and regression in autism: a review. Neuro Endocrinology Letters 2008, 29: 405-409.
87. Brynska, A., Tomaszewicz-Libudzic, C., & Wolanczyk, T. Obsessive-compulsive disorder and acquired toxoplasmosis. European Child and Adolescent Psychiatry, 2001, 10: 200-204.
88. Prandota, J. Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice. Research in Autism Spectrum Disorders 2010b, 4: 103-118.
89. Prandota, J. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances. Research in Autism Spectrum Disorders 2010c, 4: 119-155.
90. Prandota, J. Metabolic, immune, epigenetic, and endocrine abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis. Research in Autism Spectrum Disorders 2011, 4: 14-59.
91. Spear, W., Chan, D., Coppens, I., Johnson, R.S., Giaccia, A., & Blader, U. The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiology 2006, 8: 339-352.
92. Wenger, R.H., Rolfs, A., Marti, H.H., Bauer, C. & Gassmann, M. Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. Journal of Biological Chemistry 1995, 270: 27865-27870.
93. Yan, S.F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. Journal of Biological Chemistry 1995, 270: 11463-11471.
94. Scannel, G. Leukocyte responses to hypoxic/ischemia conditions. New Horizons 1996, 4: 179-183.
95. Willis, D., Moore, A.R., Frederick, R., & Willoughby, D.A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Natural Medicine 1996, 2: 87-90.
96. Ji, Y.S., Xu, Q. & Schmedtje, J.F. Jr Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium. Circulation Research 1998, 83: 295-304.
97. Zhang, W., Smith, C., Howlett, C. & Stanimirovic, D. Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta. Journal of Cerebral Blood Flow and Metabolism 2000, 20: 967-978.
98. Stanimirovic, D., Zhang, W., Howlett, C., Lemieux, P. & Smith, C. Inflammatory gene transcription in human astrocytes exposed to hypoxia: roles of the nuclear factor-kappaB and autocrine stimulation. Journal of Neuroimmunology 2001, 119: 365-376.
99. Haddad, J.J. & Harb, H.L. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. International Immunopharmacology 2005, 5: 461-483.
100. Min, K.-J., Yang, M., Kim S.-U., Jou, I., & Joe E. Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. Journal of Neuroscience 2006, 26: 1880-1887.
101. Lam, S.Y., Tipoe, G.L., Liong, E.C. & Fung, M.L. Chronic hypoxia upregulates the expression and function of proinflammatory cytokines in the rat carotid body. Histochemistry and Cell Biology 2008, 130: 549-559.
102. Xu, J., He, L., Ahmed, S.H., Chen, S.W., Goldberg, M.P., Beckman, J.S. & Hsu, C.Y. Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 2000, 31: 1744-1751.
103. Clanton, T.L. Hypoxia-induced reactive oxygen species formation in skeletal muscle. Journal of Applied Physiology 2007, 102: 2379-2388.
104. Lu, D.Y., Liou, H.C., Tang, C.H., & Fu, W.M. Hypoxia-induced iNOS expression in microglia is regulated by the Pl3 kinase/Akt/mTOR signalling pathway and activation of hypoxia inducible factor-1alpha. Biochemical Pharmacology 2006, 72: 992-1000.
105. Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydrolases. Molecular Biology of the Cell 2003, 14: 3470-3481.
106. Dulak, J., Józkowicz, A., Dembinska-Kiec, A., Guevara, I., Zdzieniecka, A., Zmudzinska-Grochot, D., et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arteriosclerosis and Thrombosis Vascular Biology 2000, 20: 659-666.
107. Hill-Kapturczak, N., Truong, L., Thamilselvan, V., Visner, G.A., Nick, H.S., & Agarwal, A. Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-beta in human renal epithelial cells. Journal of Biology and Chemistry, 2000, 275: 40904-40909.
108. Wilmshurst, P.T., Byrne, J.C., & Webb-Peploe, M.M. Relation between interatrial shunts and decompression sickness in divers. Lancet 1989, 2: 1302-1306.
109. Wilmshurst, P.T. & Nightingale, S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clinical Science (London) 2001, 100: 215-220.
110. Wilmshurst, P.T. Nightingale, S., Walsh, K.P., & Morrison, W.L. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005, 91: 1173-1175.
111. Shanoudy, H., Soliman, A., Raggi, P., Liu, J.W., Russell, D.C. & Jarmukli, N.F. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 1998, 113: 91-96.
112. Godart, F., Rey, C., Prat, A., Vincentelli, A., Chmait, A., Francart, C. & Porte, H. Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. European Heart Journal 2000, 21: 483-489.
113. Prandota, J. Possible pathomechanisms of sudden infant death syndrome. Key role of chronic hypoxia, infection/inflammation states, cytokine irregularities, and metabolic trauma in genetically predisposed infants. American Journal of Therapeutics 2004, 11: 517-546.
114. Prandota, J. Migraine associated with patent foramen ovale may be caused by reactivation of cerebral toxoplasmosis triggered by arterial blood oxygen desaturation. International Journal of Neuroscience 2010a, 120: 81-87.
115. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., & Pardo, C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology 2005, 57: 67-81.
116. Pardo, C.A., Vargas, D.L., & Zimmerman, A.W. Immunity, neuroglia and neuroinflammation in autism. International Review of Psychiatry 2005, 17: 485-495.
117. Yool, A.J. Aquaporins: multiple roles in the central nervous system. Neuroscientist 2007, 13: 470-485.
118. Courchesne, E., & Pierce, K. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. International Journal of Developmental Neuroscience 2005, 23: 153-170.
119. Redcay, E., & Courchesne, E. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biological Psychiatry 2005, 58: 1-9.
120. Schultz, R.T., Win, L., Jackowski, A., Klin, A., Staib, L., Papademetris, X., et al. Brain morphology in autism spectrum disorders: an MRI study. Paper presented at annual International Meeting for Autism Research, 2005, Boston, MA, May.
121. Yao, X, Hrabetova, S., Nicholson, C., & Manley, G.T. Aquaporin-4-deficient mice have increased extracellular space without tortuosity change. Journal of Neuroscience 2008, 28: 5460-2464.
122. Wen, H., Nagelhus E.A., Amiry-Moghaddam, M., Agre, P., Ottersen, O.P., & Nielsen, S. Ontogeny of water transport in rat brain: postnatal expression of the aquaporin-4 water channel. European Journal of Neuroscience 1999, 11: 935-945.